Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12624001150538
Ethics application status
Approved
Date submitted
16/01/2024
Date registered
23/09/2024
Date last updated
23/09/2024
Date data sharing statement initially provided
23/09/2024
Type of registration
Prospectively registered

Titles & IDs
Public title
Creatine and Exercise as a Novel Treatment Strategy for Depression in Adults Aged 18-39 Years
Scientific title
Creatine and Exercise as a Novel Treatment Strategy for Depression in Adults Aged 18-39 Years
Secondary ID [1] 311307 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Depression 332555 0
Condition category
Condition code
Mental Health 329246 329246 0 0
Depression
Physical Medicine / Rehabilitation 331593 331593 0 0
Other physical medicine / rehabilitation

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
There are two separate treatment arms:

Treatment Arm One: 10g Creatine per day for 6 weeks; oral (diluted in flavored cordial in an opaque bottle) without resistance training

Treatment Arm Two: 10g Creatine per day for 6 weeks; oral (diluted in flavored cordial in an opaque bottle) with resistance training as detailed below.

6 weeks resistance training, 3 times per week with at least 48 hours recovery; Whole-Body program

All exercise sessions will be supervised by selected research investigators that are first aid-trained and have previously completed their Certificate 3 and 4 in Fitness
Sessions will be one-on-one at the Swinburne University gym
Exercise intensities will range from 50-80% of a pre-determined maximum strength test and will be performed at an intensity level aiming for 7-9 out of 10 on a Borg Scale
Participants will complete three sessions per week for six weeks; each session will last between 35-45 minutes including a warm-up and warm-down.
Adherence will be monitored by counting the number of sessions completed during the six period and compared to the target of 18 sessions throughout the entire intervention.
Intervention code [1] 327752 0
Treatment: Other
Comparator / control treatment
The control/comparator group will undertake 6 weeks resistance training (3 times per week with at least 48 hours recovery; Whole-Body program; exactly the same program as detailed above) as well as receive 10g Maltodextrin per day for 6 weeks (oral; diluted in flavored cordial in an opaque bottle).
Control group
Placebo

Outcomes
Primary outcome [1] 337101 0
Depression
Timepoint [1] 337101 0
Pre-intervention (0 weeks); Post-intervention (6 weeks post intervention commencement)
Primary outcome [2] 339332 0
Depression
Timepoint [2] 339332 0
Pre-intervention (0 weeks); Post-intervention (6 weeks post intervention commencement)
Secondary outcome [1] 430717 0
Muscle Strength
Timepoint [1] 430717 0
Pre-intervention (0 weeks); Post-intervention (6 weeks post intervention commencement)
Secondary outcome [2] 430718 0
Circulating levels of Brain Derived Neutrophic Factor (BDNF)
Timepoint [2] 430718 0
Pre-intervention (0 weeks); Post-intervention (6 weeks post intervention commencement)

Eligibility
Key inclusion criteria
- Aged 18-39 years.
- Mild-moderate depression severity (scoring between 5-19 on the Patient Health Questionnaire-9, PHQ-9)
- Body mass index (BMI) is between 18.5-29.9 kg/m².
- Sedentary (less than 150 min/week exercise/ physical activity)
- Not involved in a structured exercise program involving more than 2 exercise sessions per week in the last 6 months
Minimum age
18 Years
Maximum age
39 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Hazardous alcohol or tobacco use using the AUDIT Alcohol Screening Tool
- No current or previous use of creatine supplements
- Physically active (greater than 150 min/week exercise/ physical activity)
- Serious somatic disorder based on a previous diagnosis from a Medical Doctor
- Psychiatric treatment
- Moderately severe and severe depression (PHQ-9>14 or >20 respectively).
- Body mass index (BMI) above 29.9 kg/m²
- Asthma
- Any current or history of respiratory or cardiac conditions
- Diabetes
- Pre-existing renal disease or proteinuria on baseline urinalysis testing
- History of creatinine hypersensitivity
- Concomitant treatment with antiepileptic or antipsychotic medications
- Neurological or psychiatric disorder
- Clinically significant suicidal or homicidal risk

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?

The people administering the treatment/s

Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
7/10/2024
Actual
Date of last participant enrolment
Anticipated
18/08/2025
Actual
Date of last data collection
Anticipated
31/10/2025
Actual
Sample size
Target
36
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 315560 0
Charities/Societies/Foundations
Name [1] 315560 0
Barber Dicker Sciences Brain Sciences Foundation
Country [1] 315560 0
Australia
Primary sponsor type
University
Name
Swinburne University
Address
John Street, Hawthorn, 3122
Country
Australia
Secondary sponsor category [1] 317679 0
None
Name [1] 317679 0
Address [1] 317679 0
Country [1] 317679 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 314459 0
Swinburne Human Research Ethics Committee
Ethics committee address [1] 314459 0
Ethics committee country [1] 314459 0
Australia
Date submitted for ethics approval [1] 314459 0
30/01/2024
Approval date [1] 314459 0
25/07/2024
Ethics approval number [1] 314459 0
Ethics committee name [2] 316092 0
Swinburne University of Technology Human Research Ethics Committee
Ethics committee address [2] 316092 0
Ethics committee country [2] 316092 0
Australia
Date submitted for ethics approval [2] 316092 0
30/01/2024
Approval date [2] 316092 0
25/07/2024
Ethics approval number [2] 316092 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 131658 0
Dr Donny Camera
Address 131658 0
Swinburne University; Department of Health and Biostatistics; Room SPW224 Mail H21 PO Box 218 Hawthorn Vic, 3122
Country 131658 0
Australia
Phone 131658 0
+61 403166127
Fax 131658 0
Email 131658 0
dcamera@swin.edu.au
Contact person for public queries
Name 131659 0
Donny Camera
Address 131659 0
Swinburne University; Department of Health and Biostatistics; Room SPW224 Mail H21 PO Box 218 Hawthorn Vic, 3122
Country 131659 0
Australia
Phone 131659 0
+61 403166127
Fax 131659 0
Email 131659 0
dcamera@swin.edu.au
Contact person for scientific queries
Name 131660 0
Donny Camera
Address 131660 0
Swinburne University; Department of Health and Biostatistics; Room SPW224 Mail H21 PO Box 218 Hawthorn Vic, 3122
Country 131660 0
Australia
Phone 131660 0
+61 403166127
Fax 131660 0
Email 131660 0
dcamera@swin.edu.au

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.